Clinical Insights

Clinical Insights: January 4, 2022

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Adbry™ (tralokinumab-ldrm) Injection – New Drug Approval – December 27, 2021 – Leo Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Adbry™ (tralokinumab-ldrm)…

Read More...

Clinical Insights: December 28, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Leqvio® (inclisiran) Injection – New Drug Approval – December 22, 2021 – Novartis announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and…

Read More...

Clinical Insights: December 22, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Apretude™ (cabotegravir) Extended-Release Injectable Suspension – New Drug Approval – December 20, 2021 – The U.S. Food and Drug Administration approved Apretude™ (cabotegravir extended-release injectable suspension) for use…

Read More...

Clinical Insights: December 14, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Xaciato™ (clindamycin phosphate) Vaginal Gel – New Drug Approval – December 7, 2021 – Daré Bioscience, Inc., a leader in women’s health innovation, announced that the U.S. Food…

Read More...

Clinical Insights: December 7, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval PreHevbrio™ (hepatitis B vaccine (recombinant)) Injection – New Vaccine Approval – November 30, 2021 – VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of…

Read More...

Clinical Insights: December 1, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Cytalux™ (pafolacianine) Injection – New Drug Approval – November 29, 2021 – The U.S. Food and Drug Administration approved Cytalux™ (pafolacianine), an imaging drug intended to assist surgeons…

Read More...

Clinical Insights: November 23, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Voxzogo™ (vosoritide) Injection – New Drug Approval – November 19, 2021 – The U.S. Food and Drug Administration approved Voxzogo™ (vosoritide) injection to improve growth in children five…

Read More...

Clinical Insights: November 16, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Besremi® (ropeginterferon alfa-2b-njft) Injection – New Drug Approval – November 12, 2021 – The U.S. Food and Drug Administration approved Besremi® (ropeginterferon alfa-2b-njft) injection to treat adults with…

Read More...

Clinical Insights: November 9, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Scemblix® (asciminib) Tablets – New Orphan Drug Approval – October 29, 2021 – The Food and Drug Administration granted accelerated approval to asciminib (Scemblix®, Novartis AG) for patients…

Read More...

Clinical Insights: November 2, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval No new update. New Indication/Dosage/Formulation Approval No new update. New/Updated Drug Shortage November 01, 2021 Clobetasol Propionate Topical Solution, 0.05% (Discontinuation) Meloxicam Tablets (Discontinuation) October 29, 2021 Amino…

Read More...

Clinical Insights: October 26, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval No new update. New Indication/Dosage/Formulation Approval Dupixent® (dupilumab) Injection – New Expanded Indication Approval – October 20, 2021 – The U.S. Food and Drug Administration (FDA) has approved…

Read More...

Clinical Insights: October 19, 2021

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Tavneos™ (avacopan) – New Orphan Drug Approval – October 8, 2021 – ChemoCentryx, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Tavneos™ (avacopan), an…

Read More...